Clinical Trials in Pennsylvania

Showing 8761-8780 of 19,675 trials

Repisodic & Skilled Nursing Facility Preferred Provider Networks

NCT04263779

This study tests whether changing the relative order of presentation of post acute care skilled nursing facilities (SNFs) in the Repisodic application, i.e., presenting preferred SNFs (P-SNFs) first, increases selection of, and discharges to, P-SNFs and decreases lengths of stay (LoS) for Geisinger patients discharged to SNFs. Along with the order of P-SNFs, the study also assesses whether a short video reviewing the benefits of care coordination in P-SNFs increases patient election to transfer to one.

Skilled Nursing FacilitiesBehavioral Economics

Geisinger Clinic5,581 participantsStarted May 2021

Danville, Pennsylvania, United States

COMPLETEDPhase 371 miles

TAC Versus TC for Adjuvant Breast Cancer

NCT00493870

The purpose of this research study is to find out what effects (good and bad) TC or TAC has on early stage HER2- breast cancer.

Breast Cancer

US Oncology Research1,961 participantsStarted May 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sedona, Arizona, United States +92 more locations

Repisodic & Skilled Nursing Facility Preferred Provider Networks

TAC Versus TC for Adjuvant Breast Cancer

Find Trials by Condition in Pennsylvania

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

Expanded Access Protocol Using 131I-MIBG

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Bacteriophage Therapy in Patients With Urinary Tract Infections

Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors